101 related articles for article (PubMed ID: 17634345)
1. Differential sensitivity of GABA A receptor-mediated IPSCs to cannabinoids in hippocampal slices from adolescent and adult rats.
Kang-Park MH; Wilson WA; Kuhn CM; Moore SD; Swartzwelder HS
J Neurophysiol; 2007 Sep; 98(3):1223-30. PubMed ID: 17634345
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron/bouton preparation.
Inada H; Maejima T; Nakahata Y; Yamaguchi J; Nabekura J; Ishibashi H
Neuroscience; 2010 Feb; 165(4):1377-89. PubMed ID: 19961906
[TBL] [Abstract][Full Text] [Related]
3. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.
Hoffman AF; Oz M; Caulder T; Lupica CR
J Neurosci; 2003 Jun; 23(12):4815-20. PubMed ID: 12832502
[TBL] [Abstract][Full Text] [Related]
4. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
Laaris N; Good CH; Lupica CR
Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
[TBL] [Abstract][Full Text] [Related]
5. Action of methylmercury on GABA(A) receptor-mediated inhibitory synaptic transmission is primarily responsible for its early stimulatory effects on hippocampal CA1 excitatory synaptic transmission.
Yuan Y; Atchison WD
J Pharmacol Exp Ther; 1997 Jul; 282(1):64-73. PubMed ID: 9223540
[TBL] [Abstract][Full Text] [Related]
6. Differential GABAB Receptor Modulation of Ethanol Effects on GABA(A) synaptic activity in hippocampal CA1 neurons.
Wu PH; Poelchen W; Proctor WR
J Pharmacol Exp Ther; 2005 Mar; 312(3):1082-9. PubMed ID: 15615867
[TBL] [Abstract][Full Text] [Related]
7. Effects of the synthetic cannabinoid nabilone on spatial learning and hippocampal neurotransmission.
Diana G; Malloni M; Pieri M
Pharmacol Biochem Behav; 2003 Jun; 75(3):585-91. PubMed ID: 12895676
[TBL] [Abstract][Full Text] [Related]
8. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission.
Hampson AJ; Bornheim LM; Scanziani M; Yost CS; Gray AT; Hansen BM; Leonoudakis DJ; Bickler PE
J Neurochem; 1998 Feb; 70(2):671-6. PubMed ID: 9453561
[TBL] [Abstract][Full Text] [Related]
9. Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.
Hoffman AF; Oz M; Yang R; Lichtman AH; Lupica CR
Learn Mem; 2007; 14(1-2):63-74. PubMed ID: 17202425
[TBL] [Abstract][Full Text] [Related]
10. Retrograde endocannabinoid signaling in a postsynaptic neuron/synaptic bouton preparation from basolateral amygdala.
Zhu PJ; Lovinger DM
J Neurosci; 2005 Jun; 25(26):6199-207. PubMed ID: 15987949
[TBL] [Abstract][Full Text] [Related]
11. Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture.
Shen M; Thayer SA
Mol Pharmacol; 1999 Jan; 55(1):8-13. PubMed ID: 9882692
[TBL] [Abstract][Full Text] [Related]
12. CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus.
Balázsa T; Bíró J; Gullai N; Ledent C; Sperlágh B
Neurochem Int; 2008 Jan; 52(1-2):95-102. PubMed ID: 17719142
[TBL] [Abstract][Full Text] [Related]
13. GABAB receptor- and metabotropic glutamate receptor-dependent cooperative long-term potentiation of rat hippocampal GABAA synaptic transmission.
Patenaude C; Chapman CA; Bertrand S; Congar P; Lacaille JC
J Physiol; 2003 Nov; 553(Pt 1):155-67. PubMed ID: 12963794
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids modulate hippocampal memory and plasticity.
Abush H; Akirav I
Hippocampus; 2010 Oct; 20(10):1126-38. PubMed ID: 19830813
[TBL] [Abstract][Full Text] [Related]
15. The effect of a new water-soluble sedative-hypnotic drug, JM-1232(-), on long-term potentiation in the CA1 region of the mouse hippocampus.
Takamatsu I; Sekiguchi M; Yonamine R; Wada K; Kazama T
Anesth Analg; 2011 Nov; 113(5):1043-9. PubMed ID: 21788318
[TBL] [Abstract][Full Text] [Related]
16. Modulation of excitatory synaptic transmission by Delta 9-tetrahydrocannabinol switches from agonist to antagonist depending on firing rate.
Roloff AM; Thayer SA
Mol Pharmacol; 2009 Apr; 75(4):892-900. PubMed ID: 19118122
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB₁and CB₂receptors in the mouse hippocampus.
Andó RD; Bíró J; Csölle C; Ledent C; Sperlágh B
Neurochem Int; 2012 Jan; 60(2):145-52. PubMed ID: 22133429
[TBL] [Abstract][Full Text] [Related]
18. Distinctions among GABAA and GABAB responses revealed by calcium channel antagonists, cannabinoids, opioids, and synaptic plasticity in rat hippocampus.
Lafourcade CA; Alger BE
Psychopharmacology (Berl); 2008 Jul; 198(4):539-49. PubMed ID: 18097653
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus.
Slanina KA; Schweitzer P
Neuropharmacology; 2005 Oct; 49(5):653-9. PubMed ID: 15936781
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors.
Gessa GL; Melis M; Muntoni AL; Diana M
Eur J Pharmacol; 1998 Jan; 341(1):39-44. PubMed ID: 9489854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
